Certified by Founder Lodge
Cirrus Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $11,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cirrus Therapeutics is an ocular immunology-focused company co-founded by Dr. Kai Chan, former Chief Scientific Officer of Ally Therapeutics and Blavatnik Fellow at Harvard Business School, a
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 07 ,2025 | Seed | $11,000,000 |
Polaris Partners
ClavystBio
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Govstream.ai | $3,600,000 | (Dec 5, 2025)
ZincFive, Inc. | $30,000,000 | (Dec 5, 2025)
imper.ai | $28,000,000 | (Dec 5, 2025)
SPhotonix Inc | $4,500,000 | (Dec 5, 2025)
Multifactor (YC F25) | $15,000,000 | (Dec 5, 2025)
